LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down – Time to Sell?

LeMaitre Vascular, Inc. (NASDAQ:LMAT)’s share price gapped down prior to trading on Friday . The stock had previously closed at $99.91, but opened at $90.00. LeMaitre Vascular shares last traded at $90.43, with a volume of 50,253 shares traded.

Wall Street Analyst Weigh In

Several analysts have weighed in on LMAT shares. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Lake Street Capital boosted their price target on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Friday. Wells Fargo & Company started coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 price target for the company. Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Oppenheimer cut shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Friday. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $95.25.

LeMaitre Vascular Stock Down 8.1 %

The firm’s 50-day moving average is $96.89 and its 200-day moving average is $94.73. The company has a market cap of $2.07 billion, a PE ratio of 50.19, a PEG ratio of 2.22 and a beta of 0.96.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings results on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.49. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The company had revenue of $55.81 million for the quarter, compared to analysts’ expectations of $55.99 million. As a group, equities research analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

Hedge Funds Weigh In On LeMaitre Vascular

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Copeland Capital Management LLC increased its position in shares of LeMaitre Vascular by 0.7% during the fourth quarter. Copeland Capital Management LLC now owns 1,172,015 shares of the medical instruments supplier’s stock valued at $107,990,000 after buying an additional 8,623 shares during the period. State Street Corp grew its holdings in LeMaitre Vascular by 3.6% in the third quarter. State Street Corp now owns 822,085 shares of the medical instruments supplier’s stock worth $76,363,000 after purchasing an additional 28,525 shares during the period. Congress Asset Management Co. grew its holdings in LeMaitre Vascular by 1.8% in the fourth quarter. Congress Asset Management Co. now owns 722,325 shares of the medical instruments supplier’s stock worth $66,555,000 after purchasing an additional 13,009 shares during the period. Geode Capital Management LLC grew its holdings in LeMaitre Vascular by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 550,260 shares of the medical instruments supplier’s stock worth $50,711,000 after purchasing an additional 7,737 shares during the period. Finally, Northern Trust Corp grew its holdings in LeMaitre Vascular by 5.1% in the fourth quarter. Northern Trust Corp now owns 327,815 shares of the medical instruments supplier’s stock worth $30,205,000 after purchasing an additional 15,843 shares during the period. Hedge funds and other institutional investors own 84.64% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.